Investors can apply to distribute grant funding from Innovate UK with private equity investment into UK businesses to deliver innovation in the healthy ageing market. Grant funding is from the Industrial Strategy Challenge Fund.
Innovate UK, part of UK Research and Innovation, is inviting UK registered investors to partner with them. Together they will distribute a share of up to £12million in grants to micro, small or medium-sized enterprises (SMEs) and social enterprises registered in the UK, alongside private equity capital. Grant funding is from the Industrial Strategy Challenge Fund.
The aim of this competition is to encourage early private investment in innovative healthy ageing technologies, including products, services and business models. This is phase 1 of a 2 phase competition. The second phase will be open to SMEs to apply for grant funding and equity investment.
The investor partners selected will work over a two-year timeframe after they have been paid the grant funding (approximately March 2020 to March 2022) to:
- Identify innovative SMEs working in ‘healthy ageing’ technology that are suitable for investment but outside your typical risk preference, which might involve changing your target market
- Help those SMEs deliver a healthy ageing project, with 50% of the total eligible project costs grant funded and the remaining 50% from equity investment into the business
Over a further year (approximately March 2022 to March 2023) the investor partners will manage any remaining grant deployment to ongoing projects.
Grant funding will only be offered to SMEs with research and development projects considered to be highly innovative.
This partnership approach aims to improve access to the financial and commercial support SMEs need to develop and market innovations in the healthy ageing market. Investor partners must provide wider business skills, networks and experience as well as capital investment.
Phase 1: investor partners
In this competition, Innovation UK are looking for investor partners. To join as an investor partner, you must be an equity provider with an established company holding a full UK registration at Companies House. This can include charities and trusts with the power to make investments.
You can apply for a grant allocation of between £1million and £6million. In order to balance the portfolio of investor partners and ensure best value for money, Innovate UK’s offer might be different from the amount you applied for. Your application should outline the minimum amount of grant you would be prepared to operate with, and the maximum you feel you could effectively allocate.
You must be able to demonstrate that:
- Between 2020 and 2023 you can invest into innovative companies a sum that is at least equal to the grant funding they are applying for
- You can commit to give follow-on funding of at least three times the grant allocation amount to successful micro, small or medium-sized enterprises (SMEs) and social enterprises by 2025
- You have suitable arrangements in place to meet all operational requirements, such as promotion, distributing and managing public money responsibly, reporting on the portfolio performance, allocation of investments, confidentiality and data protection
Innovate UK are particularly interested in investors who can:
- Demonstrate the interest, capability and capacity needed to invest in early-stage companies, including university spin-outs and businesses looking for their first investment opportunities
- Demonstrate the ability to add value beyond their investment
- Commit to helping the company grow and scale
- Show they have access to relevant sector and technology-specific expertise
Innovate UK will decide which investors to appoint as partners. Their considerations will include (but not be limited to):
- Geographic coverage and reach
- Financial standing and good character
- Track record and/or forward plan
- Evidence of how this programme will help you to take a different approach to investing in early stage technology SMEs
Phase 2: SME projects
Once selected, each investor partner will identify suitable UK registered SMEs or social enterprises who wish to carry out an innovative research and development (R&D) project in the healthy ageing market. These can include:
- New deal flow for you
- SMEs already in your portfolio who are looking for further investment and grant funding for a specific project
You will be able to put forward SMEs to apply to an invitation-only competition from March 2020. Projects can last up to two years. Projects must end and the full grant allocation must be deployed by March 2023.
Total eligible project costs (including grant and investment) will be finalised in discussion with successful investor applicants. Innovate UK expect that projects will have total eligible costs of between £100,000 and £1.5million.
Up to £12million grant funding is available to support up to 50% of the total eligible project costs of UK registered SMEs. To receive grant funding the SME must raise at least the same amount of equity capital from an approved investor partner.
During phase 1, Innovate UK are looking to select up to six investors to partner with Innovate UK. As an investor you will receive a share of the total available grant to distribute to SMEs alongside your equity investment during phase 2.
You will be responsible for holding and distributing the allocated grant capital. All partners must comply with the requirements set out in the government’s guidance on managing public money.
Innovate UK will distribute grant capital quarterly in arrears, subject to ongoing monitoring of the project. You must provide a pro-rata amount of the equity investment either before or at the same time as the grant capital.
Investor partners can draw management fees from the grant allocation, in line with the agreed fee schedule. Innovate UK will invoice you for the following costs to be deducted from the grant allocation:
- Assessment costs for each SME application
- Monitoring costs for each funded project
The subsequent SME competition will provide state aid funding under article 25, ‘aid for research and development projects’, of the General Block Exemption Regulation 2014 (GBER).
In the SME phase of this competition, Innovate UK will not fund projects that:
- Are purely at the technical feasibility or proof of concept stage, unless they have a single, short milestone that may be required to reach go/no-go decision to rapidly move into product development and/or proof of market studies
- Are not carried out by SMEs
- Are collaborative R&D projects
- Are carried out by SMEs that are not attracting at least the same amount of private investment into the SME
- Are not part of a company’s plan for business growth
- Cannot present evidence that their idea or concept has the potential to lead to significant return on investment, growth and scale-up of the business
- Are large capital infrastructure such as new buildings
Cresco Innovation works with companies to develop and implement innovation strategies. We help client companies identify opportunities to develop new products and services, and then create a package of support to ensure that the idea is turned into a commercial reality.
Our services include securing grants (as a team we have raised around £40million over three years), business planning, IP advice, access to finance and funders, project management and IP commercialisation support.
We regularly act as the interface with the funding bodies and help clients ensure that their projects are properly managed to ensure the best outcome for all.
Rehman holds a PhD in materials sciences. He is a highly-experienced writer of bids, tender responses and proposal applications, achieving outstanding successes across a variety of funding programmes, both in the UK and EC, on behalf of clients and consultancies.